Wednesday, June 10, 2026

pharma Β· Breast Cancer Β· Multiple Sclerosis (MS)

HOFFMANN-LA ROCHE

HOFFMANN-LA ROCHE patent portfolio β€” 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Mississauga, Ontario L5N 5M8, CA HQ
10 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Mississauga, Ontario L5N 5M8, CA
Employees
10
Programs
286
Drugs
212
Patents
0
Intelligence Β· Patents

HOFFMANN-LA ROCHE patents

0 pharmaceutical patents indexed for HOFFMANN-LA ROCHE. 0 expire within 24 months.

HOFFMANN-LA ROCHE has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months β€” use filters for patent-cliff planning.

No patents matched

Try a different expiry filter or check back as we index more USPTO records.

Frequently asked questions

How many patents does HOFFMANN-LA ROCHE have?

0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do HOFFMANN-LA ROCHE patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.